VIR-2020

N/A

Report date: 2025/04/14 16:57:37

Base Information

Drug NameVIR-2020
Drug Alias NameVIR-2020
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesVir Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A